Huami Corporation and Promaxo announced a strategic partnership combining technology development, commercialization, and market expansion efforts. Huami provides smart consumer health and industrial health technologies globally, while Promaxo develops compact MRI systems with initial focus on urology applications.
The collaboration encompasses joint engineering for artificial intelligence integration, product development opportunities, and manufacturing support. Huami will facilitate commercialization of Promaxo products in China and internationally, while Promaxo intends to incorporate Huami’s wearable technology to enhance patient health monitoring before and after treatment. Huami is also conducting due diligence for potential investment consideration.
Huami’s leadership emphasized the alignment with the company’s mission: “Our company’s mission is to connect health with technology, and we are expanding the industrial side of our business.” They highlighted expertise in AI, miniaturization engineering, manufacturing, and health data analysis as valuable contributions.
Promaxo’s CEO noted the partnership accelerates market penetration through access to technical innovation and Huami’s expanding global infrastructure. The partnership reflects Huami’s 2020 strategic initiative to leverage technology, global reach, and financial resources for growth opportunities.